Yahoo
NasdaqCM - Delayed Quote USD

Estrella Immunopharma, Inc. (ESLA)

0.6393 -0.0894 (-12.27%)
At close: October 30 at 4:00:01 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
6/30/2024
6/30/2023
6/30/2022
Total Revenue
0
0
0
0
0
Operating Expense
9,682.0320
13,062.6740
7,310.0980
11,114.4020
1,685.3470
Operating Income
-9,682.0320
-13,062.6740
-7,310.0980
-11,114.4020
-1,685.3470
Pretax Income
-10,012.7510
-13,062.6740
-7,310.0980
-11,114.4020
-1,685.3470
Tax Provision
-0.0250
0.8380
1.6250
0
0
Net Income Common Stockholders
-10,012.7260
-13,063.5120
-7,311.7230
-11,114.4020
-1,685.3470
Diluted NI Available to Com Stockholders
-10,012.7260
-13,063.5120
-7,311.7230
-11,114.4020
-1,685.3470
Basic EPS
-0.25
-0.35
-0.27
-0.32
-0.05
Diluted EPS
-0.25
-0.35
-0.27
-0.32
-0.05
Basic Average Shares
40,013.2840
36,820.8100
27,103.9640
35,201.2320
35,201.2320
Diluted Average Shares
40,013.2840
36,820.8100
27,103.9640
35,201.2320
35,201.2320
Total Operating Income as Reported
-9,682.0320
-13,062.6740
-7,310.0980
-11,114.4020
-1,685.3470
Total Expenses
9,682.0320
13,062.6740
7,310.0980
11,114.4020
1,685.3470
Net Income from Continuing & Discontinued Operation
-10,012.7260
-13,063.5120
-7,311.7230
-11,114.4020
-1,685.3470
Normalized Income
-9,682.0078
-13,063.5120
-7,311.7230
-11,114.4020
-1,685.3470
EBIT
-9,682.0320
-13,062.6740
-7,310.0980
-11,114.4020
-1,685.3470
EBITDA
-9,682.0320
-13,062.6740
-7,310.0980
-11,114.4020
-1,685.3470
Net Income from Continuing Operation Net Minority Interest
-10,012.7260
-13,063.5120
-7,311.7230
-11,114.4020
-1,685.3470
Total Unusual Items Excluding Goodwill
-330.7190
--
--
--
--
Total Unusual Items
-330.7190
--
--
--
--
Normalized EBITDA
-9,351.3130
-13,062.6740
-7,310.0980
-11,114.4020
-1,685.3470
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
-0.0008
0
0
0
0
6/30/2022 - 9/14/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: